跳至主要内容
临床试验/NCT00375687
NCT00375687Unknown不适用

Investigation of Early Hormonotherapy Efficacy of High Risk Patients for Progression of Prostate Cancer After Radical Prostatectomy

Kaunas University of Medicine2 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2005年8月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
61
试验地点
2
主要终点
Survival

研究概览

简要总结

The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.

详细描述

The primary purpose of this study is to evaluate the hypothesis, that early administration of adjuvant hormonotherapy (triptorelin) can prolong survival data for high risk patients. Control group (randomised study) will be treated with hormonotherapy, when PSA recidive appear (on demand treatment). Secondary purposes will be to compare PSA dinamics and quality of life data in the groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • preoperative PSA>20ng/ml
  • postoperative PSA >0.2 ng/ml
  • Gleason > 7
  • signated infomed consent

排除标准

  • neoadjuvant hormonaltherapy before RP
  • unstable cncomitant conditions

结局指标

主要结局

Survival

次要结局

  • PSA dinamics
  • quality of life

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Investigation of Early Hormonotherapy Efficacy of... | 临床试验